Mkare Pharmaceuticals Private Limited
About Mkare Pharmaceuticals Private Limited
Data last updated:
Mkare Pharmaceuticals Private Limited is a private limited company based in Amritsar, Punjab, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 26 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24304PB2017PTC046539. Its GSTIN is 03AALCM0969N1Z0 (Punjab).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sharan Sharma and Sania Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO – 5 – 6 S.G. Tower S.G. Enclave Majitha Road, Amritsar, Punjab, India – 143001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.55 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹8.89 Lakh (net margin 5.7%) and EBITDA of ₹23.31 Lakh (EBITDA margin 15%). Revenue has grown at a compounded annual rate (CAGR) of 137% over three years.
As per MCA filings, the company has open charges of ₹45 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mkare Pharmaceuticals Private Limited's registered office is in Amritsar, Punjab. Its e-mail address is in the company report.
- Email
- Registered AddressSCO – 5 – 6 S.G. Tower S.G. Enclave Majitha Road, Amritsar, Punjab, India – 143001
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Mkare Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mkare Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mkare Pharmaceuticals Private Limited, buy the company report.
Financials of Mkare Pharmaceuticals Private Limited
FY 2025 filings availableMkare Pharmaceuticals Private Limited reported revenue of ₹1.55 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 137% over three years, including 10% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.31 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.89 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mkare Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mkare Pharmaceuticals Private Limited
Mkare Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharan Sharma Also directs: As Signature Hotel and Resorts LLP, Sarvcon Infra Private Limited | Director | 26 May 2017 | 9 Years 5 Months | Current |
| Sania Sharma | Additional Director | 22 May 2020 | 6 Years 5 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Aug 2023 | 100779325 | Hdfc Bank Limited | ₹45 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Mkare Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mkare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mkare Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AALCM0969N1Z0 | Punjab | Active | 18 May 2020 |
To see the full GST registrations and return filing status of Mkare Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mkare Pharmaceuticals Private Limited has 6 board changes on record since 2017: 2 appointments and 4 cessations. The latest: Esha Chopra ceased to be Additional Director on 15 Apr 2022.
Frequently asked questions
Mkare Pharmaceuticals is an active private limited company based in Amritsar, Punjab, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 26 May 2017 (9+ years old) and is registered under CIN U24304PB2017PTC046539.
Mkare Pharmaceuticals has 2 current directors:
- Sharan Sharma - Director
- Sania Sharma - Additional Director
The latest financial statements of Mkare Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Mkare Pharmaceuticals is 03AALCM0969N1Z0, registered in Punjab.
The CIN (Corporate Identification Number) of Mkare Pharmaceuticals is U24304PB2017PTC046539. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mkare Pharmaceuticals was incorporated on 26 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chandigarh.
Esha Chopra ceased to be Additional Director on 15 Apr 2022. Krishan Kumar Sharma ceased to be Additional Director on 22 May 2020. Sania Sharma was appointed as Additional Director on 22 May 2020. Mkare Pharmaceuticals has 6 board changes on record in total.
The registered office of Mkare Pharmaceuticals is at SCO – 5 – 6 S.G. Tower S.G. Enclave Majitha Road, Amritsar, Punjab, India – 143001.
Mkare Pharmaceuticals operates in the food and beverages industry, in the artificial fibres segment.
Mkare Pharmaceuticals has open charges of ₹45 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
